Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
about
Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motifStructural implications of Siglec-5-mediated sialoglycan recognitionSiglecs and immune regulationSialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharidesThe T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria.Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position.Multifarious roles of sialic acids in immunity.Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation.Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells.Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling.Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phaseBasic and clinical immunology of SiglecsPD-1 signaling in primary T cellsCD33-related siglecs as potential modulators of inflammatory responses.Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.Distinct Oral Neutrophil Subsets Define Health and Periodontal Disease States.Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities.A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins.Enhanced lentiviral vector production in 293FT cells expressing Siglec-9.Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes.Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β2-integrin-dependent function in human eosinophils.Expression of Siglec-E Alters the Proteome of Lipopolysaccharide (LPS)-Activated Macrophages but Does Not Affect LPS-Driven Cytokine Production or Toll-Like Receptor 4 Endocytosis.
P2860
Q21144548-CC7BECA4-1169-4267-A805-865F4CA99889Q24646384-478F6477-694D-4916-827E-2249FDDEA385Q26992091-56598237-AD38-4F1F-8226-518179869C1DQ28247592-A85A42B9-07F9-4235-8EBB-B9742B584E84Q30381101-2B854731-7805-4EA3-8FB8-9F2538B02FA2Q30829904-9B6C2192-E01A-4AEE-9EB5-1D3D06E4F335Q33243531-18A28DED-40E7-4856-AC1F-1A12D4496016Q34270155-E751E858-1FC4-415B-AECB-BE87CA8B9B92Q34903504-E69948D8-8887-45B8-8361-51580146D391Q35556765-A5926B09-8483-4FC2-8C3E-7617110390B8Q35950210-FF36F625-D4E9-4C6C-BFB4-57CDC04E142EQ36154801-1A4675BE-1D96-4D7D-B38E-405A53EA202EQ36572813-3A31A1E5-3E4A-4219-AE4A-B6E4B567580CQ36682863-7370D225-E8F4-4674-8C5E-BB500EF2A4B5Q36691835-EEC3DB79-1CE8-4B08-BB5E-BCD21184D650Q37017472-3F0C4F00-8FF1-4C98-B368-FF6FBAD862A6Q37348437-B4116E62-7C35-4467-867B-623450EFE3ABQ37474915-64BB89C0-A793-45A4-A876-ACDF34760263Q37986851-75543B3E-9100-4D3C-B429-FD9D0331D329Q38674244-AA698BD9-15F4-41D1-9C84-99A09A89AB3EQ38857619-095A90EC-6329-465B-AFDE-16A9F6DDE94CQ39677106-8B4766F8-D6F6-4048-AB62-AFDB5A9A4B24Q40225148-4EDA33A8-1635-4120-A625-5713A1A607B4Q41207923-47974155-2EDE-40E0-A34B-8B40E2B6941FQ41835254-CDA573B0-D7CB-4554-874B-93376952F8E7Q42133647-61854778-2A10-4AA6-82B5-3E725DFC8418Q42767129-21B1B227-2940-4189-BEBF-99D7EF762D6AQ46309701-C07C6388-5FFA-47DF-A986-E3C175AABE07Q49209369-1CF36D40-953A-4A19-90C5-F47B937207EA
P2860
Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Siglec-5 (CD170) can mediate i ...... ibitory motif phosphorylation.
@ast
Siglec-5 (CD170) can mediate i ...... ibitory motif phosphorylation.
@en
Siglec-5
@nl
type
label
Siglec-5 (CD170) can mediate i ...... ibitory motif phosphorylation.
@ast
Siglec-5 (CD170) can mediate i ...... ibitory motif phosphorylation.
@en
Siglec-5
@nl
prefLabel
Siglec-5 (CD170) can mediate i ...... ibitory motif phosphorylation.
@ast
Siglec-5 (CD170) can mediate i ...... ibitory motif phosphorylation.
@en
Siglec-5
@nl
P2093
P2860
P356
P1476
Siglec-5 (CD170) can mediate i ...... hibitory motif phosphorylation
@en
P2093
Helen Attrill
Rosemary G Clarke
Tony Avril
P2860
P304
19843-19851
P356
10.1074/JBC.M502041200
P407
P577
2005-03-15T00:00:00Z